NANA E.Coli

N-Acetylneuraminate Lyase E.Coli Recombinant
Shipped with Ice Packs
In Stock

Description

Enzymatic Activity and Inhibition

NANA functions as a Class I aldolase, forming a Schiff-base intermediate during catalysis. Key biochemical properties include:

  • Substrate: N-acetylneuraminic acid (Km = 2.5 mM)

  • Reaction Products: Pyruvate and N-acetyl-D-mannosamine

  • Inhibitors:

    • Cu²⁺ ions, p-chloromercuribenzoate, N-bromosuccinimide

    • Competitive inhibitors: Pyruvate, dihydroxyacetone, DL-glyceraldehyde

Enzyme activity is abolished by NaBH₄ reduction in the presence of substrate, confirming its Schiff-base mechanism .

Genetic and Regulatory Features

The nanA gene (located at 70–80 min on the E. coli genetic map) encodes NANA lyase and is part of the sialic acid utilization operon . Key findings:

  • Cloning: The nanA gene was self-cloned in E. coli, resulting in constitutive expression and 2–3× higher activity compared to wild-type strains .

  • Regulation: Induced by NANA availability and regulated by methylation stress. Exposure to methyl methanesulfonate (MMS) reduces NanA expression by ~60%, impairing biofilm formation .

Role in Biofilm Formation and Pathogenesis

Proteomic studies reveal that NanA downregulation under methylation stress correlates with:

  • Reduced biofilm formation in E. coli

  • Decreased adhesion to human epithelial cells (HeLa and Caco-2)

  • Impaired invasion by pathogenic E. coli LF82 (AIEC)

This highlights NanA’s role in bacterial colonization and infection mechanisms .

Enzyme Kinetics and Inhibitor Sensitivity

Comparative studies of NanA variants show divergent biochemical behaviors:

ParameterE. coli K-12Strain 22-1 (Mutant)Pathogenic Strains
Specific Activity (U/mg)0.074–0.130 0.001–0.002 Variable
Ca²⁺ SensitivityLowN/AHigh
Oseltamivir IC₅₀Not applicableN/A10–50 μM

Pathogenic strains exhibit higher sensitivity to neuraminidase inhibitors, suggesting therapeutic targeting potential .

Applications in Microbial Physiology

NANA lyase is integral to E. coli carbon metabolism, enabling utilization of sialic acid derivatives. Key pathways include:

  1. NANA Catabolism:

    • NANA → Pyruvate + ManNAc (via NanA)

    • ManNAc → GlcNAc-6-P (via ManXYZ transporter and epimerase)

  2. Convergent Metabolism: GlcNAc-6-P enters glycolysis via NagBA enzymes .

Product Specs

Introduction
N-acetylneuraminate lyase (NanA), an enzyme belonging to the oxo-acid-lyase family, plays a crucial role in cleaving carbon-carbon bonds. Specifically, NanA catalyzes the breakdown of N-acetylneuraminic acid (sialic acid) into pyruvate and N-acetyl-D-mannosamine. Its classification as a Class I aldolase is supported by its inhibition upon reduction with NaBH₄ in the presence of its substrate, a characteristic of Schiff-base-forming aldolases. NanA's activity is significantly hampered by Cu²⁺ ions, p-chloromercuribenzoate, and N-bromosuccinimide. Furthermore, its activity is competitively inhibited by pyruvate, the product of the reaction it catalyzes, as well as structurally similar compounds like dihydroxyacetone and DL-glyceraldehyde.
Description
Produced in E. coli, NANA is a single, non-glycosylated polypeptide chain consisting of 317 amino acids, with the first 297 amino acids forming the NANA protein. With a molecular weight of 34.7kDa, it includes a 20 amino acid His-tag fused at the N-terminus. The purification process involves proprietary chromatographic techniques.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
The NANA protein solution is prepared at a concentration of 1mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0) and 20% glycerol.
Stability
For optimal storage, the product should be kept at 4°C if it will be used entirely within 2-4 weeks. For prolonged storage, freezing at -20°C is recommended. To further enhance long-term stability, the addition of a carrier protein (0.1% HSA or BSA) is advised. Repeated freezing and thawing cycles should be avoided.
Purity
SDS-PAGE analysis indicates a purity greater than 95%.
Synonyms
N-acetylneuraminate lyase, N-acetylneuraminate pyruvate-lyase, N-acetylneuraminic acid aldolase, NALase, Sialate lyase, Sialic acid aldolase, Sialic acid lyase, nanA, npl, b3225, JW3194.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MATNLRGVMA ALLTPFDQQQ ALDKASLRRL VQFNIQQGID GLYVGGSTGE AFVQSLSERE QVLEIVAEEA KGKIKLIAHV GCVSTAESQQ LAASAKRYGF DAVSAVTPFY YPFSFEEHCD HYRAIIDSAD GLPMVVYNIP ALSGVKLTLD QINTLVTLPG
VGALKQTSGD LYQMEQIRRE HPDLVLYNGY DEIFASGLLA GADGGIGSTY NIMGWRYQGI VKALKEGDIQ TAQKLQTECN KVIDLLIKTG VFRGLKTVLH YMDVVSVPLC RKPFGPVDEK YLPELKALAQ QLMQERG.

Q&A

What is N-acetylneuraminate lyase (NanA) in E. coli?

N-acetylneuraminate lyase (also known as N-acetylneuraminic acid aldolase, NALase, sialate lyase, or sialic acid aldolase) is an enzyme that catalyzes the reversible aldol cleavage of N-acetylneuraminic acid (sialic acid; Neu5Ac) to form pyruvate and N-acetylmannosamine (ManNAc) via a Schiff base intermediate . The enzyme belongs to the family of lyases, specifically the oxo-acid-lyases, which cleave carbon-carbon bonds . In E. coli, this enzyme is encoded by the nanA gene (also referred to as npl or b3225) .

What is the substrate specificity of NanA?

Recent research has clarified that the true substrate for NanA is aceneuramate (linearized Neu5Ac), which forms spontaneously at alkaline pH . This contradicts earlier assumptions that the enzyme acts on the alpha-anomer of Neu5Ac. The enzyme can also cleave other substrates such as N-glycollylneuraminic acid (GcNeu), but not colominic acid or various 2-oxocarboxylic acids including 2-oxohexanoic acid, 2-oxo-octanoic acid, 2-oxo-3-deoxyoctanoic acid, and 2-oxononanoic acid .

How is the nanA gene regulated in E. coli?

The nanA gene in E. coli is regulated by the transcriptional repressor NanR, a GntR-type repressor that controls sialic acid metabolism . NanR functions by binding cooperatively to a DNA sequence containing three GGTATA repeats with high affinity (apparent KD of 39 ± 2 nM) . The effector molecule, N-acetylneuraminate, binds to NanR and causes a conformational change that weakens its DNA binding, thus alleviating repression and allowing transcription of genes involved in sialic acid metabolism, including nanA .

What is the protein structure of NanA?

NanA from E. coli is a protein consisting of 297 amino acids . The protein has been successfully crystallized, with crystals diffracting to better than 2.0 Å resolution, enabling detailed structural studies . The enzyme forms a multimeric structure that plays a crucial role in its catalytic function. The crystallographic structure reveals specific domains involved in substrate binding and catalysis.

How does the mechanism of NanA's substrate preference affect experimental design?

The discovery that NanA preferentially metabolizes the open form (aceneuramate) of Neu5Ac, which comprises <0.5% of total Neu5Ac in solution (compared to ~92% beta-anomer and ~7% alpha-anomer), has significant implications for experimental design .

When conducting kinetic studies with NanA, researchers should understand that:

  • The rate-limiting step in standard assays is not the aldolase activity but the spontaneous conversion of cyclic forms to the linear form .

  • Reaction pH critically influences results, with alkaline conditions (pH 7-8) accelerating the spontaneous anomerization of Neu5Ac .

  • For accurate kinetic measurements, researchers should consider using:

    • Spectrophotometric assays where pyruvate formation is coupled to NADH consumption via lactate dehydrogenase

    • Anomerases such as NanM or YhcH to accelerate the conversion to the linear form

    • pH optimization based on experimental goals

Table 1: Effect of pH on NanA Reaction Rates With and Without Anomerases

ConditionpH 6.0pH 7.0pH 8.0
NanA aloneVery slowModerate (~5× faster than pH 6)Fast (>5× faster than pH 6)
NanA + NanM (0.05 μM)Fast (>20× faster than NanA alone)Moderately enhancedMinimally enhanced
NanA + YhcHEnhanced (requires ~10× higher concentration than NanM)Moderately enhancedMinimally enhanced

This table demonstrates how pH and anomerases dramatically influence reaction rates, with the most pronounced effects at lower pH where spontaneous anomerization is slowest .

What methodological approaches can resolve contradictions in substrate specificity studies?

Contradictions in substrate specificity studies, such as earlier reports suggesting that NanA acts on the alpha-anomer of Neu5Ac, can be resolved through carefully designed experiments:

  • Control pH conditions: Conducting experiments at pH 6, where spontaneous anomerization is slow, allows researchers to distinguish between enzyme activity and substrate conversion effects .

  • Compare substrates with different conformational distributions: Using:

    • 2-keto-3-deoxyxylonate (~30% present in open form) as a control substrate

    • 2-keto-3-deoxynonanoate (KDN, primarily in cyclic forms) for comparison with Neu5Ac

    • Testing whether anomerases affect reaction rates with these substrates helps determine if they act by modifying the substrate or by directly enhancing enzyme activity

  • Cross-species enzyme testing: Using human NPL (which shares only ~30% sequence identity with E. coli NanA) can help determine whether anomerases act through direct protein interaction (which would be unlikely across distantly related enzymes) or by modifying substrate availability .

What are the optimal strategies for cloning and expressing the nanA gene?

Based on published research, effective strategies for cloning and expressing nanA include:

  • Vector selection:

    • The pKKtac expression vector containing the strong tac promoter has proven effective for nanA expression .

    • Self-cloning in E. coli has been successful, with transformants selected by complementation of NANA lyase-deficient strains .

  • Expression host:

    • E. coli remains the preferred expression host, with successful expression reported using the nanA gene from both E. coli and Haemophilus influenzae .

    • Expression of H. influenzae nanA in E. coli has yielded enzyme with more than threefold greater specific activity (6.9 IU/mg) compared to the E. coli enzyme (≤2 IU/mg) .

  • Protein tagging considerations:

    • N-terminal His-tags may interfere with protein structure and function in some related proteins (as observed with YhcH) .

    • C-terminal His-tags have been successfully used for purification .

  • Purification protocol:

    • Effective purification of NanA has been achieved through a sequence of:
      a) Protamine sulfate treatment
      b) Ammonium sulfate fractionation
      c) Column chromatography on DEAE-Sephacel
      d) Gel filtration on Ultrogel AcA 44
      e) Preparative polyacrylamide gel electrophoresis

    • Quality control should confirm the absence of contaminating enzymes including NADH oxidase and NADH dehydrogenase .

How do anomerases influence NanA activity and what experimental setups best demonstrate this relationship?

The discovery that anomerases (NanM and YhcH) significantly enhance NanA activity by providing the linear substrate has important implications for research design. Optimal experimental setups include:

  • Concentration-dependent studies:

    • NanM is highly efficient, with half-maximal stimulation at ~0.05 μM, approximately 40-fold lower than the concentration of NanA (2 μM) .

    • YhcH requires about 10-fold higher concentration than NanM to achieve similar enhancement effects .

  • Control experiments to distinguish mechanism:

    • Using 2-keto-3-deoxyxylonate (largely present in open form) as a substrate, where anomerases show no enhancing effect, confirms they act by providing the open substrate rather than directly activating the enzyme .

    • Testing with different substrates like KDN (deamino analogue of Neu5Ac) demonstrates that the N-acetylamino group of Neu5Ac is not essential for anomerase activity .

  • Cross-species validation:

    • Both NanM and YhcH from E. coli stimulate human NPL activity on Neu5Ac despite low sequence homology, supporting the substrate modification mechanism rather than direct enzyme interaction .

Table 2: Comparison of Anomerase Effects on NanA Activity

AnomeraseRelative Concentration RequiredEffect on Neu5Ac MetabolismEffect on 2-keto-3-deoxyxylonateEffect on KDNEffect on Human NPL
NanMLow (0.05 μM)Strong enhancementNo enhancementEnhancementEnhancement
YhcHHigher (~10× NanM)Moderate enhancementNo enhancementEnhancementEnhancement

This table summarizes the differential effects of anomerases on various substrates and enzymes, providing insights into their mechanism of action .

What approaches are used to study NanR-mediated regulation of nanA?

The regulation of nanA by NanR involves cooperative protein-DNA interactions that can be studied through:

  • Electrophoretic mobility shift assays (EMSAs):

    • EMSAs reveal the formation of three distinct hetero-complexes as NanR binds to the (GGTATA)3-repeat operator .

    • Quantitative analysis yields an apparent dissociation constant (KD) of 39 ± 2 nM and a Hill coefficient (n) of 2.0 ± 0.2, demonstrating high-affinity, cooperative binding .

  • Analytical ultracentrifugation:

    • This technique confirms EMSA findings with slightly higher affinity (KD = 20 ± 1 nM and n = 1.9 ± 0.2) .

    • The sedimentation coefficient distribution shows the development of three additional peaks corresponding to NanR-DNA complexes as NanR concentration increases .

  • DNA sequence requirements:

    • NanR binds poorly to oligonucleotides containing just one GGTATA repeat, with binding similar to non-specific control DNA .

    • The presence of multiple GGTATA repeats is crucial for cooperative, high-affinity binding .

  • Structural studies:

    • Single-particle cryo-electron microscopy structures reveal how the DNA-binding domain is reorganized to engage DNA, while three dimers assemble in close proximity across the (GGTATA)3-repeat operator .

    • The crystal structure of NanR in complex with N-acetylneuraminate reveals a domain rearrangement upon binding that weakens DNA binding .

What crystallization conditions yield high-resolution structures of NanA?

For researchers seeking to determine the structure of NanA or engineer the enzyme based on structural insights:

  • Recombinant expression systems can produce NanA with >95% purity suitable for crystallization .

  • Orthorhombic crystals of NanA diffract to better than 2.0 Å resolution, enabling detailed structural analysis .

  • The structural data reveals:

    • The catalytic mechanism involving a Schiff base intermediate

    • Specific residues involved in substrate binding and catalysis

    • Potential sites for engineering enzyme properties

Product Science Overview

Introduction

N-Acetylneuraminate lyase (NAL), also known as sialic acid aldolase, is an enzyme that catalyzes the reversible cleavage of N-acetylneuraminic acid (Neu5Ac) into N-acetyl-D-mannosamine (ManNAc) and pyruvate . This enzyme is part of the lyase family, specifically the oxo-acid-lyases, which cleave carbon-carbon bonds . The recombinant form of this enzyme, produced in Escherichia coli (E. coli), has significant applications in biochemical research and industrial processes.

Function and Mechanism

NAL plays a crucial role in the metabolism of sialic acids, which are essential components of glycoproteins and glycolipids in many organisms . The enzyme’s activity involves the formation of a Schiff base intermediate, facilitating the aldol cleavage of Neu5Ac . This reaction is reversible, allowing NAL to also catalyze the synthesis of Neu5Ac from ManNAc and pyruvate .

Production in E. Coli

Recombinant protein production in E. coli is a widely used method due to the bacterium’s well-characterized genetics, rapid growth, and high-yield production capabilities . The gene encoding NAL is cloned into an expression vector, which is then introduced into E. coli cells. Upon induction, the recombinant E. coli produces NAL, which can be purified using various chromatographic techniques .

Applications
  1. Biochemical Research: NAL is used in the study of sialic acid metabolism and its role in various biological processes. Its ability to catalyze both the cleavage and synthesis of Neu5Ac makes it a valuable tool for investigating sialic acid pathways .
  2. Industrial Production: The enzyme is employed in the production of sialic acids, which are high-value sugars used in pharmaceuticals and biotechnology . Recombinant NAL from E. coli is particularly useful due to its high activity and stability .
  3. Diagnostic Tools: NAL’s binding ability is utilized in functional assays such as ELISA (Enzyme-Linked Immunosorbent Assay), Western Blotting (WB), and Immunoprecipitation (IP) .
Structural Features

The recombinant NAL produced in E. coli typically includes a His-tag to facilitate purification. The enzyme consists of 297 amino acids and has a molecular weight of approximately 34.7 kDa . The His-tagged version allows for easy purification using nickel-affinity chromatography .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.